曾因IPO文件不齐遭中止审查的华大基因近期卷土重来。3月14日晚间,华大基因在证监会网站更新披露招股说明书,拟在深交所创业板发行不低于4000万股。在华大基因更新招股书的当晚,证监会就立即发函质询,一连串提出了59个问题,不仅就华大基因历年来股权变动情况、重组及对外投资情况、相关机构股东的适格性、销售模式、产销情况等规 The Huada gene, which had been censored for lack of IPO documents, has recently returned. On the evening of March 14, Huada Gene was updated on the website of the CSRC to disclose the prospectus and intended to issue no less than 40 million shares on the GEM of the Shenzhen Stock Exchange. On the night of the prospectus of China Genomics Update, the CSRC immediately sent a letter asking 59 questions in a series. Not only the changes in equity, restructuring and overseas investment of ACWG over the years, the suitability of the shareholders of relevant agencies, Sales model, production and marketing regulations